Table 2.
Risk of major adverse cardiovascular event over the follow-up according to SAF at baseline
| HR | 95% Confidence interval | p | |
|---|---|---|---|
| SAF (per 1 AU) | 4.13 | 1.30; 13.07 | 0.02 |
| Sex | |||
| Men | 4.15 | 0.87; 19.77 | 0.07 |
| BMI (per 1 kg/m2) | 1.11 | 0.96; 1.27 | 0.16 |
| MACE at baseline | |||
| Yes | 3.01 | 0.99; 9.08 | 0.05 |
| Statins baseline | |||
| Yes | 2.55 | 0.77; 8.47 | 0.13 |
| eGFR (mL/min) | |||
| < 60 | 1.54 | 0.32; 7.31 | 0.59 |
| Albumin excretion rate (mg/24 h) | |||
| ≥ 30 | 1.92 | 0.54; 6.88 | 0.32 |
| Hypertension | |||
| Yes | 2.70 | 0.61; 11.98 | 0.19 |
| Diabetes duration in 2009 (per 1 year) | 1.02 | 0.98; 1.06 | 0.38 |
Cox multivariate analysis (n = 205, 21 events)